Investor Overview

Webcast ImageWebcast
ViewRay Inc at Cowen and Company 37th Annual Health Care Conference (Live)
03/06/17 at 1:20 p.m. ET
ViewRay Inc at Cowen and Company 37th Annual Health Care Conference
Monday, March 6, 2017 1:20 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Newsmore >
02/22/17ViewRay® to Participate in Upcoming Conferences
CLEVELAND, Feb. 22, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences. The first conference is the 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah from February 28, 2017 through March 2, 2017. This conference will allow institutional investors to meet with the Company but does not i... 
01/24/17Private Japanese Hospital Purchases ViewRay MRIdian System
CLEVELAND, Jan. 24, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Edogawa Hospital in Tokyo Japan has purchased a MRIdian system, the world's first and only clinical MRI-guided radiation therapy system, as part of an expansion of the hospital's cancer center. The MRIdian system is a unique medical instrument that integrates an MRI with cobalt radiation delivery to treat cancer. Using the MRIdian system, clinicians can see soft tissue, and visualize and adjust the dose... 
01/19/17German Research Foundation (DFG) Purchases ViewRay MRIdian Linac for University Clinic Heidelberg
Marks First Purchase of MRIdian Linac in Europe following CE Mark Approval CLEVELAND, Jan. 19, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the German Research Foundation (DFG), a federal institution supporting research in Germany, has purchased a MRIdian Linac for installation and patient treatments at the University Clinic Heidelberg as part of its initiative for MRI-based radiation therapy. The MRIdian Linac program will be headed by Medical Director and Profes... 
01/18/17ViewRay Raises $26.1 Million in Private Placement
Financing to Support Commercialization of MRIdian Linear Accelerator Technology CLEVELAND, Jan. 18, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), makers of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has raised aggregate gross proceeds of approximately $26.1 million through a private placement of its common stock and warrants. Puissance Capital Management led the financing and was joined by certain of ViewRay's existing investors, incl... 
Corporate Profile

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first and only MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian® addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian®’s increased target accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who would not previously have been considered radiation therapy candidates. ViewRay believes MRIdian® will significantly improve the safety and efficacy of radiation therapy, leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Featured Items
Download Documentation Investor Presentation
Upcoming Eventsmore >
Prior to
ViewRay Inc at 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference
03/06/17 1:20 p.m. ET
ViewRay Inc at Cowen and Company 37th Annual Health Care Conference
Enter your e-mail address 
Stock Quotemore >
VRAY (Common Stock)
Exchange :NASDAQ (US Dollar)
Price :$4.76
Change (%) :0.00 (0.00%)
Volume :0
Data as of 02/24/17 4:00 p.m. ET
Event Calendarmore >
February 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High
Formats:  HTML Adobe PDF Word
Formats:  Excel HTML Adobe PDF Word
Formats:  HTML Adobe PDF Word
SC 13G
Formats:  HTML Adobe PDF Word
Formats:  HTML Adobe PDF Word
Formats:  HTML Adobe PDF Word
Formats:  HTML Adobe PDF Word
Formats:  HTML Adobe PDF Word
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever ViewRay Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed.
Copyright 2015 © ViewRay. All rights reserved